308 related articles for article (PubMed ID: 19101982)
1. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.
Cieply B; Zeng G; Proverbs-Singh T; Geller DA; Monga SP
Hepatology; 2009 Mar; 49(3):821-31. PubMed ID: 19101982
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.
Tao J; Krutsenko Y; Moghe A; Singh S; Poddar M; Bell A; Oertel M; Singhi AD; Geller D; Chen X; Lujambio A; Liu S; Monga SP
Hepatology; 2021 Aug; 74(2):741-759. PubMed ID: 33529367
[TBL] [Abstract][Full Text] [Related]
3. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
Ando S; Shibahara J; Hayashi A; Fukayama M
Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
[TBL] [Abstract][Full Text] [Related]
4. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.
Torbenson M; McCabe CE; O'Brien DR; Yin J; Bainter T; Tran NH; Yasir S; Chen ZE; Dhanasekaran R; Ahn KS; Roberts LR; Wang C
Hum Pathol; 2022 Jan; 119():15-27. PubMed ID: 34592239
[TBL] [Abstract][Full Text] [Related]
5. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
6. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
7. Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
Okabe H; Kinoshita H; Imai K; Nakagawa S; Higashi T; Arima K; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Ishiko T; Yoshizumi T; Beppu T; Monga SP; Baba H; Maehara Y
PLoS One; 2016; 11(4):e0152695. PubMed ID: 27100093
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
Rebouissou S; Franconi A; Calderaro J; Letouzé E; Imbeaud S; Pilati C; Nault JC; Couchy G; Laurent A; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Hepatology; 2016 Dec; 64(6):2047-2061. PubMed ID: 27177928
[TBL] [Abstract][Full Text] [Related]
9. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
[TBL] [Abstract][Full Text] [Related]
10. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP
Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
[TBL] [Abstract][Full Text] [Related]
11. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
[TBL] [Abstract][Full Text] [Related]
15. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
17. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
18. β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
Lu LC; Shao YY; Lee YH; Hsieh MS; Hsiao CH; Lin HH; Kao HF; Ma YY; Yen FC; Cheng AL; Hsu CH
Oncology; 2014; 87(3):159-66. PubMed ID: 25012536
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma.
Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M
Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
